VHLHGNC PubMedNew recommendation

Hereditary kidney tumor syndromes: structured evaluation of a questionnaire-based approach.

Degenhardt J, von Zehmen T, Beck B, et al. — Clin Kidney J 2026 · June 2026

Relevance score

6/10

Disease / domain

Hereditary renal tumor predisposition syndromes (VHL, TSC, BHD, HLRCC)

Gene / mechanism

Structured risk assessment tool (hRCC score) for identifying patients at risk of hereditary renal cell carcinoma

Summary

This study prospectively validates a structured questionnaire-based risk assessment tool (hRCC score) for identifying patients at risk of hereditary renal cell carcinoma. Up to 8% of renal tumors have a monogenic cause (VHL, TSC, Birt-Hogg-Dubé, HLRCC), yet these syndromes remain underdiagnosed. The tool is validated on a prospective cohort to systematize oncogenetics referral from initial urological workup.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

A prospectively validated simple triage tool for hereditary renal tumors addresses a real need: urologists do not systematically consider genetic origin of renal carcinoma outside obvious bilateral or familial forms. The hRCC score could integrate easily into urology consultations.

Analysis by Dr Thibaut Benquey

Why this score?

Clinical impact: 3/3 · Evidence strength: 2/3 · Novelty: 0/2 · Sample size: 1/1 · Publication status: 0/1 → Total: 6/10

Keywords

hereditary renal cell carcinomaVHLBirt-Hogg-Dubéscreeningoncogenetics